Gilead Sciences
GILD
#106
Rank
A$261.43 B
Marketcap
A$210.84
Share price
0.17%
Change (1 day)
16.99%
Change (1 year)

Gilead Sciences (GILD) - Net assets

Net assets on the balance sheet as of June 2026 : A$16.83 Billion

According to Gilead Sciences's latest financial reports the company has A$16.83 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Gilead Sciences - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$A$33.76 B9.13%
2024-12-31$A$30.94 B-7.33%
2023-12-31$A$33.39 B7.14%
2022-12-31$A$31.16 B7.27%
2021-12-31$A$29.05 B22.61%
2020-12-31$A$23.69 B-26.75%
2019-12-31$A$32.35 B5.83%
2018-12-31$A$30.56 B16.4%
2017-12-31$A$26.25 B-2.24%
2016-12-31$A$26.86 B2.39%
2015-12-31$A$26.23 B35.73%
2014-12-31$A$19.32 B46.8%
2013-12-31$A$13.16 B43.38%
2012-12-31$A$9.18 B37.12%
2011-12-31$A$6.69 B11.13%
2010-12-31$A$6.02 B-16.78%
2009-12-31$A$7.24 B14.41%
2008-12-31$A$6.32 B53.7%
2007-12-31$A$4.11 B73.71%
2006-12-31$A$2.37 B-42.71%
2005-12-31$A$4.13 B71.16%
2004-12-31$A$2.41 B79.17%
2003-12-31$A$1.34 B33.06%
2002-12-31$A$1.01 B14.39%
2001-12-31$A$0.88 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
A$121.78 B 623.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$122.53 B 627.96%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
-A$8.44 Billion-150.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$48.55 B 188.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$16.75 B-0.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$27.01 B 60.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$3.83 B-77.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$29.02 B 72.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$60.17 B 257.49%๐Ÿ‡บ๐Ÿ‡ธ USA